Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 1320-1328, April 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mollinedo, F.
Right arrow Articles by Modolell, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mollinedo, F.
Right arrow Articles by Modolell, M.

Selective Induction of Apoptosis in Cancer Cells by the Ether Lipid ET-18-OCH3 (Edelfosine): Molecular Structure Requirements, Cellular Uptake, and Protection by Bcl-2 and Bcl-XL1

Faustino Mollinedo2, Jose Luis Fernández-Luna, Consuelo Gajate, Belén Martín-Martín, Adalberto Benito, Rosa Martínez-Dalmau and Manuel Modolell

Laboratory of Leukocyte Biology, Instituto de Biología y Genética Molecular, Facultad de Medicina, CSIC-Universidad de Valladolid, C/Ramón y Cajal 7, E-47005 Valladolid, Spain [F. M., C. G., B. M-M., R. M-D.]; Servicio de Inmunología, Hospital Universitario Marques de Valdecilla, INSALUD, E-39008 Santander, Spain [J. L. F-L., A. B.]; and Max-Planck-Institut für Immunbiologie, D-79108 Freiburg, Germany [M. M.]

The ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3; Edelfosine) has been shown to be a rapid inducer of apoptosis in human leukemic cells and has been considered as a promising drug in cancer treatment. Here we have found that Et-18-OCH3 induced apoptosis not only in human tumor cell lines but also in primary tumor cell cultures from cancer patients. Human leukemic cells were highly sensitive to ET-18-OCH3, whereas normal cells remained unaffected. Among the distinct modifications of the ET-18-OCH3 molecule assayed, we found that substitutions in positions sn-2 and sn-3 of the glycerol backbone resulted in a complete loss of its capacity to induce apoptosis, highlighting the importance of the molecular structure of ET-18-OCH3 in its apoptotic effect. Induction of apoptosis by ET-18-OCH3 was very well correlated with the uptake of this ether lipid. ET-18-OCH3-resistant 3T3 fibroblasts became sensitive and incorporated significant amounts of the ether lipid following transformation with the SV40 virus. ET-18-OCH3-induced apoptosis as well as ET-18-OCH3 uptake were not mediated through binding of the ether lipid to the platelet-activating factor receptor. Overexpression of bcl-2 or bcl-xL by gene transfer in the human erythroleukemic HEL cells abrogated apoptosis induced by ET-18-OCH3. ET-18-OCH3 did not affect the expression of bcl-2, bcl-xL, or bax in HEL and HL-60 human leukemic cells but induced expression of c-myc, an important effector of apoptosis in several systems. Thus, ET-18-OCH3 behaves as a potent and highly selective antitumor drug able to induce an apoptotic pathway of cell death in tumor cells but not in nonmalignant cells.

1 This work was supported in part by Grant FIS96/1434 from Fondo de Investigación Sanitaria, Grant VA71/96 from Junta de Castilla y León, Grant SAF96/0274 from Comision Interministerial de Ciencia y Tecnología, Grant PB95/0713 from Dirección General de Ciencia y Tecnología, and Grants 168A and AI-40/96 from Acciones Integradas Hispano-Alemanas. C. G. is a recipient of a fellowship from "Fondo de Investigación Sanitaria."

2 To whom requests for reprints should be addressed. Phone: 34-83-423062; Fax: 34-83-423588.

Received 10/ 9/96. Accepted 2/ 2/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Nieto-Miguel, R. I. Fonteriz, L. Vay, C. Gajate, S. Lopez-Hernandez, and F. Mollinedo
Endoplasmic Reticulum Stress in the Proapoptotic Action of Edelfosine in Solid Tumor Cells
Cancer Res., November 1, 2007; 67(21): 10368 - 10378.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. H. van der Luit, S. R. Vink, J. B. Klarenbeek, D. Perrissoud, E. Solary, M. Verheij, and W. J. van Blitterswijk
A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells
Mol. Cancer Ther., August 1, 2007; 6(8): 2337 - 2345.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Gajate and F. Mollinedo
Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts
Blood, January 15, 2007; 109(2): 711 - 719.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Nyakern, A. Cappellini, I. Mantovani, and A. M. Martelli
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways.
Mol. Cancer Ther., June 1, 2006; 5(6): 1559 - 1570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nieto-Miguel, C. Gajate, and F. Mollinedo
Differential Targets and Subcellular Localization of Antitumor Alkyl-lysophospholipid in Leukemic Versus Solid Tumor Cells
J. Biol. Chem., May 26, 2006; 281(21): 14833 - 14840.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Zaremberg, C. Gajate, L. M. Cacharro, F. Mollinedo, and C. R. McMaster
Cytotoxicity of an Anti-cancer Lysophospholipid through Selective Modification of Lipid Raft Composition
J. Biol. Chem., November 11, 2005; 280(45): 38047 - 38058.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Rahmani, E. Reese, Y. Dai, C. Bauer, S. G. Payne, P. Dent, S. Spiegel, and S. Grant
Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species
Cancer Res., March 15, 2005; 65(6): 2422 - 2432.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Gajate, E. del Canto-Janez, A. U. Acuna, F. Amat-Guerri, E. Geijo, A. M. Santos-Beneit, R. J. Veldman, and F. Mollinedo
Intracellular Triggering of Fas Aggregation and Recruitment of Apoptotic Molecules into Fas-enriched Rafts in Selective Tumor Cell Apoptosis
J. Exp. Med., August 2, 2004; 200(3): 353 - 365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J. Perez-Victoria, F. Gamarro, M. Ouellette, and S. Castanys
Functional Cloning of the Miltefosine Transporter: A NOVEL P-TYPE PHOSPHOLIPID TRANSLOCASE FROM LEISHMANIA INVOLVED IN DRUG RESISTANCE
J. Biol. Chem., December 12, 2003; 278(50): 49965 - 49971.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. K. Hanson, L. Malone, J. L. Birchmore, and J. W. Nichols
Lem3p Is Essential for the Uptake and Potency of Alkylphosphocholine Drugs, Edelfosine and Miltefosine
J. Biol. Chem., September 19, 2003; 278(38): 36041 - 36050.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Gajate, F. An, and F. Mollinedo
Rapid and Selective Apoptosis in Human Leukemic Cells Induced by Aplidine through a Fas/CD95- and Mitochondrial-mediated Mechanism
Clin. Cancer Res., April 1, 2003; 9(4): 1535 - 1545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Gajate, F. An, and F. Mollinedo
Differential Cytostatic and Apoptotic Effects of Ecteinascidin-743 in Cancer Cells. TRANSCRIPTION-DEPENDENT CELL CYCLE ARREST AND TRANSCRIPTION-INDEPENDENT JNK AND MITOCHONDRIAL MEDIATED APOPTOSIS
J. Biol. Chem., October 25, 2002; 277(44): 41580 - 41589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. H. van der Luit, M. Budde, P. Ruurs, M. Verheij, and W. J. van Blitterswijk
Alkyl-lysophospholipid Accumulates in Lipid Rafts and Induces Apoptosis via Raft-dependent Endocytosis and Inhibition of Phosphatidylcholine Synthesis
J. Biol. Chem., October 11, 2002; 277(42): 39541 - 39547.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Gajate and F. Mollinedo
The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells
Blood, December 15, 2001; 98(13): 3860 - 3863.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Sano, X. Zhu, H. Sano, N. M. Munoz, E. Boetticher, and A. R. Leff
Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA2
Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L844 - L851.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. S. VRABLIC, C. D. ALBRIGHT, C. N. CRACIUNESCU, R. I. SALGANIK, and S. H. ZEISEL
Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes
FASEB J, August 1, 2001; 15(10): 1739 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Gajate, I. Barasoain, J. M. Andreu, and F. Mollinedo
Induction of Apoptosis in Leukemic Cells by the Reversible Microtubule-disrupting Agent 2-Methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by Bcl-2 and Bcl-XL and Cell Cycle Arrest
Cancer Res., May 1, 2000; 60(10): 2651 - 2659.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
D. Strassheim, S. H. Shafer, S. H. Phelps, and C. L. Williams
Small Cell Lung Carcinoma Exhibits Greater Phospholipase C-{beta}1 Expression and Edelfosine Resistance Compared with Non-Small Cell Lung Carcinoma
Cancer Res., May 1, 2000; 60(10): 2730 - 2736.
[Abstract] [Full Text]


Home page
BloodHome page
O. Cuvillier, E. Mayhew, A. S. Janoff, and S. Spiegel
Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling
Blood, November 15, 1999; 94(10): 3583 - 3592.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. A. Ruiter, S. F. Zerp, H. Bartelink, W. J. van Blitterswijk, and M. Verheij
Alkyl-Lysophospholipids Activate the SAPK/JNK Pathway and Enhance Radiation-induced Apoptosis
Cancer Res., May 1, 1999; 59(10): 2457 - 2463.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gajate, A. Santos-Beneit, M. Modolell, and F. Mollinedo
Involvement of c-Jun NH2-Terminal Kinase Activation and c-Jun in the Induction of Apoptosis by the Ether Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
Mol. Pharmacol., April 1, 1998; 53(4): 602 - 612.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. P. Whitman, F. Civoli, and L. W. Daniel
Protein Kinase Cbeta II Activation by 1-beta -D-Arabinofuranosylcytosine Is Antagonistic to Stimulation of Apoptosis and Bcl-2alpha Down-regulation
J. Biol. Chem., September 19, 1997; 272(38): 23481 - 23484.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.